The aim is to develop and validate a model that predicts the survival benefit of liver transplantation for patients with unresectable hepatocellular carcinoma.
Development of the HCC-LTSB model based on existing data.
Validation of the model against UNOS criteria for liver transplantation.
Comparison with standard allocation methods.
The HCC-LTSB model accurately predicts survival benefit from liver transplantation.
It meets UNOS criteria for candidates with unresectable HCC.
Improved decision-making in patient selection for transplants.
Abstract
The HCC-LTSB model accurately predicted the survival benefit provided by LT in candidates listed with unresectable HCC within UNOS criteria.